Mengistu M
Department of Internal Medicine, Tikur Anbessa Hospital, Addis Ababa, Ethiopia.
East Afr Med J. 1992 Sep;69(9):515-9.
One hundred and ten Ethiopian thyrotoxic patients were studied between February 1986 and January 1991 in a weekly endocrine clinic of Tikur Anbessa Teaching Hospital (TATH) in Addis Ababa, Ethiopia. This gives an incidence of 22 patients per year. There were 14 males and 96 females (M:F = 1:7). Fifty three patients (48.2%) had Graves' hyperthyroidism, 37 (33.7%) toxic multinodular goitre (TMNG), 14 (12.7%) toxic adenoma, 4 (3.6%) Jodbasedow phenomenon and 2 (1.8%) had thyroiditis. The mean age was 29.2 +/- 9.8 (+/- S.D.) years for Graves' cases, 49.0 +/- 10.9 years for TMNG cases and 46.4 +/- 15.9 years for toxic adenoma cases. The clinical presentation was similar to other reported series. The majority (88.7%) of Graves' patients were below 40 years while 75.7% of TMNG patients were over 40 years of age; this is in keeping with the observed younger age incidence of Graves' hyperthyroidism and older age incidence of TMNG. All patients responded to propylthiouracil therapy and no major side effect was recognized. Nine patients underwent sub-total thyroidectomy of whom one became hypothyroid a year later. One became toxic after a year, while 6 remained euthyroid 3 years after the surgery; the other patient did not return subsequently. The result of this study shows that thyrotoxicosis is not a rare condition in Ethiopia.
1986年2月至1991年1月期间,在埃塞俄比亚亚的斯亚贝巴的提库尔·安贝萨教学医院(TATH)每周一次的内分泌门诊中,对110名埃塞俄比亚甲状腺毒症患者进行了研究。这得出每年有22名患者的发病率。有14名男性和96名女性(男:女 = 1:7)。53名患者(48.2%)患有格雷夫斯甲亢,37名(33.7%)患有毒性多结节性甲状腺肿(TMNG),14名(12.7%)患有毒性腺瘤,4名(3.6%)患有碘致甲亢现象,2名(1.8%)患有甲状腺炎。格雷夫斯病例的平均年龄为29.2±9.8(±标准差)岁,TMNG病例为49.0±10.9岁,毒性腺瘤病例为46.4±15.9岁。临床表现与其他报道的系列相似。大多数(88.7%)格雷夫斯患者年龄在40岁以下,而75.7%的TMNG患者年龄超过40岁;这与观察到的格雷夫斯甲亢的年轻发病年龄和TMNG的老年发病年龄一致。所有患者对丙硫氧嘧啶治疗均有反应,未发现重大副作用。9名患者接受了甲状腺次全切除术,其中1名在一年后出现甲状腺功能减退。1名在一年后出现甲亢,而6名在手术后3年仍保持甲状腺功能正常;另一名患者随后未再来复诊。这项研究的结果表明,甲状腺毒症在埃塞俄比亚并非罕见疾病。